Acutely administered clozapine does not modify naloxone-induced withdrawal jumping in morphine-dependent mice

Pharmacology Biochemistry and Behavior

Volumn 62, Issue 2, 1999, Pages 285-290

  Ballard, Theresa M ^a   McAllister, Kevin H ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Clonidine; Clozapine; Haloperidol; Jumping; Mice; Morphine withdrawal; Naloxone

Indexed keywords

CLONIDINE; CLOZAPINE; HALOPERIDOL; MORPHINE; NALOXONE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG WITHDRAWAL; INTRAPERITONEAL DRUG ADMINISTRATION; JUMPING; LOCOMOTION; MALE; MORPHINE ADDICTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ANALGESICS; ANIMALS; ANTIPSYCHOTIC AGENTS; CLONIDINE; CLOZAPINE; HALOPERIDOL; MALE; MICE; MORPHINE DEPENDENCE; NALOXONE; NARCOTIC ANTAGONISTS; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0032939931     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(98)00141-5     Document Type: Article

References (35)

1. Acquas E., DiChiara G. Depression of mesolimbic dopamine transmission and sensitization to morphine during opiate abstinence. J. Neurochem. 58:1992;1620-1625.
2. Airio J., Attila M., Leikola-Pelho T., Ahtee L. Withdrawal from repeated morphine sensitises mice to the striatal dopamine release enhancing effect of acute morphine. Naunyn Schmiedebergs Arch. Pharmacol. 350:1994;548-554.
3. Baldino F. Jr., Cowan A., Geller E.B., Adler M.W. Effects of antipsychotic and antianxiety drugs on the morphine abstinence syndrome in rats. J. Pharmacol. Exp. Ther. 208:1979;63-66.
4. Bassareo V., Tanda G., Di Chiara G. Increase of extracellular dopamine in the medial prefrontal cortex during spontaneous and naloxone-precipitated opiate abstinence. Psychopharmacology (Berlin). 122:1995;202-205.
5. Brent P.J., Chahl L.A. Enhancement of the opiate withdrawal response by antipsychotic drugs in guinea-pigs is not mediated by sigma binding sites. Eur. Neuropsychopharmacol. 3:1993;23-32.
6. Casey D. Clozapine. Neuroleptic-induced EPS and tardive dyskinesia Psychopharmacology (Berlin). 99:1989;S47-S53.
7. Cervo L., Rochat C., Romandini S., Samanin R. Evidence of a preferential role of brain serotonin in the mechanisms leading to naloxone-precipitated compulsive jumping in morphine-dependent rats. Psychopharmacology (Berlin). 74:1981;271-274.
8. 2-adrenoceptor agonists on the expression of morphine-withdrawal in rats. Naunyn Schmiedebergs Arch. Pharmacol. 345:1992;553-557.
9. Coward D.M., Imperato A., Urwyler S., White T.G. Biochemical and behavioural properties of clozapine. Psychopharmacology (Berlin). 99:1989;S6-S12.
10. Esposito E., Kruszewska A., Ossowska G., Samanin R. Noradrenergic and behavioural effects of naloxone injected in the locus coeruleus of morphine-dependent rats and their control by clonidine. Psychopharmacology (Berlin). 93:1987;393-396.
11. Ferrari F., Baggio G. Influence of lisuride on morphine withdrawal signs in the rat. A dopamine-mimetic effect Psychopharmacology (Berlin). 78:1982;326-330.
12. Gomaa A.A., Mohamed L.H., Ahmed H.N. Modification of morphine-induced analgesia, tolerance and dependence by bromocriptine. Eur. J. Pharmacol. 170:1989;129-135.
13. Goodwin G.M., Metz A. Neuroleptics. Grahame-Smith D.G. Psychopharmacology 2, Part 1. Preclinical psychopharmacology:1985;206-238 Elsevier, Amsterdam.
14. Ichikawa J., Meltzer H.Y. Differential effects of repeated treatment with haloperidol and clozapine on dopamine release and metabolism in the striatum and nucleus accumbens. J. Pharmacol. Exp. Ther. 256:1991;348-357.
15. Iwamoto E.T., Ho I.K., Way E.L. Elevation of brain dopamine during naloxone-precipitated withdrawal in morphine-dependent mice and rats. J. Pharmacol. Exp. Ther. 187:1973;558-567.
16. Kane J., Honigfeld G., Singer J., Meltzer H. Clozapine for the treatment-resistant schizophrenic. Arch. Gen. Psychiatry. 45:1988;789-796.
17. Kantak K.M., Miczek K.A. Social, motor, and autonomic signs of morphine withdrawal. Differential sensitivities to catecholaminergic drugs in mice Psychopharmacology (Berlin). 96:1988;468-476.
18. Kosersky D.S., Harris R.A., Harris L.S. Naloxone-precipitated jumping activity in mice following the acute administration of morphine. Eur. J. Pharmacol. 26:1974;122-124.
19. Kuschinsky K., Hornykiewicz O. Effects of morphine on striatal dopamine metabolism. Possible mechanism of its opposite effect on locomotor activity in rats and mice Eur. J. Pharmacol. 26:1974;41-50.
20. Maruyuma Y., Takemori A.E. The role of dopamine and norepinephrine in the naloxone-induced abstinence of morphine-dependent mice. J. Pharmacol. Exp. Ther. 185:1973;602-608.
21. Moghaddam B., Bunney B.S. Acute effects of typical and atypical antipsychotic drugs on the release of dopamine from prefrontal cortex, nucleus accumbens, and striatum of the rat. An in vivo microdialysis study J. Neurochem. 54:1990;1755-1760.
22. Rossetti Z.L., Hmaidan Y., Gessa G.L. Marked inhibition of mesolimbic dopamine release. A common feature of ethanol, morphine, cocaine and amphetamine abstinence in rats Eur. J. Pharmacol. 221:1992;227-234.
23. Samanin R., Cervo L., Rochat C., Poggesi E., Mennini T. Reduction in the number of serotonin receptors in the brainstem of morphine dependent rats. Relation to blockade of naloxone precipitated jumping by serotonin agonists Life Sci. 27:1980;1141-1146.
24. Schulteis G., Heyser C.J., Koob G.F. Opiate withdrawal signs precipitated by naloxone following a single exposure to morphine. Potentiation with a second morphine exposure Psychopharmacology (Berlin). 129:1997;56-65.
25. Siegel S. Nonparametric statistics for the behavioural sciences (International student edition). 1956;McGraw-Hill Book Company Inc, Tokyo, Japan.
26. Skarsfeldt T. Differential effects after repeated treatment with haloperidol, clozapine, thioridazine and tefludazine on SNC and VTA dopamine neurones in rats. Life Sci. 42:1988;1037-1044.
27. Skuza G., Rogoz Z., Wieczorek A. Neuropsychopharmacological profile of remoxipride in comparison with clozapine. Pol. J. Pharmacol. 49:1997;5-15.
28. Slater P., Blundell C. Effects of morphine on amphetamine-induced circling and striatal cyclic AMP in rats and mice. Neuropharmacology. 18:1979;705-708.
29. Tanganelli S., Antonelli T., Morari M., Bianchi C., Beani L. Glutamate antagonists prevent morphine withdrawal in mice and guinea pigs. Neurosci. Lett. 122:1991;270-272.
30. Tseng L.-F., Loh H.H., Wei E.T. Effects of clonidine on morphine withdrawal signs in the rat. Eur. J. Pharmacol. 30:1975;93-99.
31. Vahid-Ansari F., Nakabeppu Y., Robertson G.S. Contrasting effects of chronic clozapine, SeroquelTM (ICI 204,636) and haloperidol administration on FosB-like immunoreactivity in the rodent forebrain. Eur. J. Neurosci. 8:1996;927-936.
32. Valeri P., Martinelli B., Pimpinella G., Severini C. Effects of dapiprazole, clonidine and yohimbine on the development of dependence and withdrawal behaviour in mice. Drug Alcohol Depend. 23:1989;73-77.
33. 2-receptors Naunyn Schmiedebergs Arch. Pharmacol. 329:1985;293-298.
34. van der Laan J.W., Hillen F.C. The potentiation of morphine-withdrawal jumping by clonidine is antagonized by m-chlorophenylpiperazine and not by haloperidol. Arch. Int. Pharmacodyn. 283:1986;45-55.
35. 2) receptors in the rat brain. Brain Res. 487:1989;288-298.